DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Howard I. Scher, MD
Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center
Study ChairKOL profile → - Kim N. Chi, M.D.
British Columbia Cancer Agency - Vancouver Centre
Study Chair - Ronald De-Wit, M.D.
Erasmus University Medical Center (Netherlands)
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
222 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Center-Medical Oncology
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Bcca-Centre for the Southern Interior
Kelowna, British Columbia, Canada
- Bcca-Vancouver
Vancouver, British Columbia, Canada
- British Columbia Cancer Agency - Vancouver Island Centre
Victoria, British Columbia, Canada
- Cancer Care Manitoba
Winnipeg, Manitoba, Canada
- Dr. Leon Richard Oncology Center
Moncton, New Brunswick, Canada
- the Moncton Hospital (serha)
Moncton, New Brunswick, Canada
- Centre for Clinical Research Cancer Care Program
Halifax, Nova Scotia, Canada
- Regional Cancer Program de L'Hopital Regional de Sudbury
Greater Sudbury, Ontario, Canada
- Jaravinski Cancer Centre Hamilton Health Services
Hamilton, Ontario, Canada
- Cancer Centre of Southeastern Ontario
Kingston, Ontario, Canada
- London Regional Cancer Program
London, Ontario, Canada
- the Ottawa Hospital Regional Cancer Centre
Ottawa, Ontario, Canada
- Toronto Sunnybrook Regional Cancer Centre
Toronto, Ontario, Canada
- Windsor Regional Cancer Centre
Windsor, Ontario, Canada
- Mcgill University
Montreal, Quebec, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
- Department of Radiation and Oncology of Teaching Hospital Motol
Prague, Czechia
- Institute of Radiation Oncology of Teaching Hospital Na Bulovce
Prague, Czechia
- Teaching Hospital Kralovske Vinohrady
Prague, Czechia
- Universitätsklinikum Köln
Cologne, 50931, Germany
- Gemeinschaftspraxis Für Hämatologie & Onkologie
Augsburg, Germany
- Facharzt F. Urologie
Bad Schwartau, Germany
- Urologische Praxis
Bautzen, Germany
- Klinik Am Urban
Berlin, Germany
- Universitatsmedizin Charité
Berlin, Germany
- Universitätsmedizin Charité Campus Benjamin Franklin
Berlin, Germany
- Urologische Praxis
Berlin, Germany
- Städtisches Klinikum Braunschweig
Braunschweig, Germany
- Facharzt F. Urologie
Cottbus, Germany
- Urologische Klinik
Dresden, Germany
- Universitäsklinikum Düsseldorf
Düsseldorf, Germany
- Urologische Klinik Der Universitätsklink Düsseldorf
Düsseldorf, Germany
- Universitätsklinikum Essen
Essen, Germany
- Klinikum Fulda, Urologische Klinik
Fulda, Germany
- Urologische Praxis
Hagenow, Germany
- Urologische Gemeinschaftspraxis
Hamburg, Germany
- Medizinische Hochschule Hannover
Hanover, Germany
- Nationales Centrum Für Tumorerkrankungen
Heidelberg, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2006
- Primary completion
- —
- Completion
- 30 Nov 2007
- Last update posted
- 6 Nov 2007
- Registered enrollment
- 1,200
- Registry id
- NCT00273338
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.